29.5.2007

ENOfficial Journal of the European Union
ANNEX VI
INFORMATION REQUIREMENTS REFERRED TO IN ARTICLE 10
GUIDANCE NOTE ON FULFILLING THE REQUIREMENTS OF ANNEXES VI TO XIAnnexes VI to XI specify the information that shall be submitted for registration and evaluation purposes according toArticles 10, 12, 13, 40, 41 and 46. For the lowest tonnage level, the standard requirements are in Annex VII, and every
time a new tonnage level is reached, the requirements of the corresponding Annex have to be added. For each registration
the precise information requirements will differ, according to tonnage, use and exposure. The Annexes shall thus beconsidered as a whole, and in conjunction with the overall requirements of registration, evaluation and the duty of care.

STEP 1 — GATHER AND SHARE EXISTING INFORMATIONThe registrant should gather all existing available test data on the substance to be registered, this would include a literaturesearch for relevant information on the substance. Wherever practicable, registrations should be submitted jointly, inaccordance with Articles 11 or 19. This will enable test data to be shared, thereby avoiding unnecessary testing and reducing costs. The registrant should also collect all other available and relevant information on the substance regardlesswhether testing for a given endpoint is required or not at the specific tonnage level. This should include information fromalternative sources (e.g. from (Q)SARs, read-across from other substances, in vivo and in vitro testing, epidemiological data)
which may assist in identifying the presence or absence of hazardous properties of the substance and which can in certain
cases replace the results of animal tests.
In addition, information on exposure, use and risk management measures in accordance with Article 10 and this Annex
should be collected. Considering all this information together, the registrant will be able to determine the need to generate
further information.

STEP 2 — CONSIDER INFORMATION NEEDSThe registrant shall identify what information is required for the registration. First, the relevant Annex or Annexes to befollowed shall be identified, according to tonnage. These Annexes set out the standard information requirements, but shallbe considered in conjunction with Annex XI, which allows variation from the standard approach, where it can be justified.
In particular, information on exposure, use and risk management measures shall be considered at this stage in order todetermine the information needs for the substance.

STEP 3 — IDENTIFY INFORMATION GAPS
The registrant shall then compare the information needs for the substance with the information already available andidentify where there are gaps. It is important at this stage to ensure that the available data is relevant and has sufficientquality to fulfil the requirements.

STEP 4 — GENERATE NEW DATA/PROPOSE TESTING STRATEGY
In some cases it will not be necessary to generate new data. However, where there is an information gap that needs to befilled, new data shall be generated (Annexes VII and VIII), or a testing strategy shall be proposed (Annexes IX and X),
depending on the tonnage. New tests on vertebrates shall only be conducted or proposed as a last resort when all otherdata sources have been exhausted.
In some cases, the rules set out in Annexes VII to XI may require certain tests to be undertaken earlier than or in addition
to the standard requirements.

NOTES
Note 1: If it is not technically possible, or if it does not appear scientifically necessary to give information, the reasons
shall be clearly stated, in accordance with the relevant provisions.
Note 2: The registrant may wish to declare that certain information submitted in the registration dossier is commerciallysensitive and its disclosure might harm him commercially. If this is the case, he shall list the items and provide a justification.

L 136/99

L 136/100

EN

Official Journal of the European Union

INFORMATION REFERRED TO IN ARTICLE 10(a) (i) TO (v)1.

GENERAL REGISTRANT INFORMATION1.1.

Registrant

1.1.1. Name, address, telephone number, fax number and e-mail address
1.1.2. Contact person
1.1.3. Location of the registrant's production and own use site(s), as appropriate
1.2.

Joint submission of data
Articles 11 or 19 foresee that parts of the registration may be submitted by a lead registrant on behalf of otherregistrants.
In this case, the lead registrant shall identify the other registrants specifying:— their name, address, telephone number, fax number and e-mail address,— parts of the present registration which apply to other registrants.
Mention the number(s) given in this Annex or Annexes VII to X, as appropriate.
Any other registrant shall identify the lead registrant submitting on his behalf specifying:— his name, address, telephone number, fax number and e-mail address,— parts of the registration which are submitted by the lead registrant.
Mention the number(s) given in this Annex or Annexes VII to X, as appropriate.

1.3

Third party appointed under Article 4

1.3.1. Name, address, telephone number, fax number and e-mail address
1.3.2. Contact person
2.

IDENTIFICATION OF THE SUBSTANCE
For each substance, the information given in this section shall be sufficient to enable each substance to be identified. If it is not technically possible or if it does not appear scientifically necessary to give information on one ormore of the items below, the reasons shall be clearly stated.

2.1.

Name or other identifier of each substance

2.1.1. Name(s) in the IUPAC nomenclature or other international chemical name(s)2.1.2. Other names (usual name, trade name, abbreviation)
2.1.3. EINECS or ELINCs number (if available and appropriate)
2.1.4. CAS name and CAS number (if available)
2.1.5. Other identity code (if available)
2.2.

Information related to molecular and structural formula of each substance2.2.1. Molecular and structural formula (including SMILES notation, if available)
2.2.2. Information on optical activity and typical ratio of (stereo) isomers (if applicable and appropriate)2.2.3. Molecular weight or molecular weight range
2.3.

Composition of each substance2.3.1. Degree of purity ( %)2.3.2. Nature of impurities, including isomers and by-products
2.3.3. Percentage of (significant) main impurities
2.3.4. Nature and order of magnitude (… ppm, … %) of any additives (e.g. stabilising agents or inhibitors)
2.3.5. Spectral data (ultra-violet, infra-red, nuclear magnetic resonance or mass spectrum)

29.5.200729.5.2007

EN

Official Journal of the European Union

2.3.6. High-pressure liquid chromatogram, gas chromatogram
2.3.7. Description of the analytical methods or the appropriate bibliographical references for the identification of thesubstance and, where appropriate, for the identification of impurities and additives. This information shall be sufficient to allow the methods to be reproduced.

3.

INFORMATION ON MANUFACTURE AND USE(S) OF THE SUBSTANCE(S)3.1.

Overall manufacture, quantities used for production of an article that is subject to registration, and/or imports intonnes per registrant per year in:
the calendar year of the registration (estimated quantity)

3.2.

In the case of a manufacturer or producer of articles: brief description of the technological process used in manufacture or production of articles.
Precise details of the process, particularly those of a commercially sensitive nature, are not required.

3.3.

An indication of the tonnage used for his own use(s)3.4.

Form (substance, preparation or article) and/or physical state under which the substance is made available to downstream users. Concentration or concentration range of the substance in preparations made available to downstream
users and quantities of the substance in articles made available to downstream users.

3.5.

Brief general description of the identified use(s)3.6.

Information on waste quantities and composition of waste resulting from manufacture of the substance, the use inarticles and identified uses

3.7.

Uses advised against (see Safety Data Sheet heading 16)
Where applicable, an indication of the uses which the registrant advises against and why (i.e. non-statutory recommendations by supplier). This need not be an exhaustive list.

4.

CLASSIFICATION AND LABELLING

4.1.

The hazard classification of the substance(s), resulting from the application of Articles 4 and 6 of Directive
67/548/EEC.
In addition, for each entry, the reasons why no classification is given for an endpoint should be provided (i.e. if
data are lacking, inconclusive, or conclusive but not sufficient for classification).

4.2.

The resulting hazard label for the substance(s), resulting from the application of Articles 23, 24 and 25 of Directive
67/548/EEC.

4.3.

Specific concentration limits, where applicable, resulting from the application of Article 4(4) of Directive
67/548/EEC and Articles 4 to 7 of Directive 1999/45/EC.

5.

GUIDANCE ON SAFE USE CONCERNING:
This information shall be consistent with that in the Safety Data Sheet, where such a Safety Data Sheet is required
according to Article 31.

5.1.

First-aid measures (Safety Data Sheet heading 4)

5.2.

Fire-fighting measures (Safety Data Sheet heading 5)

5.3.

Accidental release measures (Safety Data Sheet heading 6)

5.4.

Handling and storage (Safety Data Sheet heading 7)

5.5.

Transport information (Safety Data Sheet heading 14)
Where a Chemical Safety Report is not required, the following additional information is required:

5.6.

Exposure controls/personal protection (Safety Data Sheet heading 8)

5.7.

Stability and reactivity (Safety Data Sheet heading 10)

L 136/101

L 136/102

EN
5.8.

Official Journal of the European UnionDisposal considerations

5.8.1. Disposal considerations (Safety Data Sheet heading 13)
5.8.2. Information on recycling and methods of disposal for industry
5.8.3. Information on recycling and methods of disposal for the public.
6.

INFORMATION ON EXPOSURE FOR SUBSTANCES REGISTERED IN QUANTITIES BETWEEN 1 AND 10TONNES PER YEAR PER MANUFATCURER OR IMPORTER

6.1.

Main use category:

6.1.1. (a) industrial use; and/or(b) professional use; and/or(c) consumer use.
6.1.2. Specification for industrial and professional use:(a) used in closed system; and/or(b) use resulting in inclusion into or onto matrix; and/or(c) non-dispersive use; and/or(d) dispersive use.
6.2.

Significant route(s) of exposure:

6.2.1. Human exposure:(a) oral; and/or(b) dermal; and/or(c) inhalatory.
6.2.2. Environmental exposure:(a) water; and/or(b) air; and/or(c) solid waste; and/or(d) soil.
6.3.

Pattern of exposure:(a) accidental/infrequent; and/or(b) occasional; and/or(c) continuous/frequent.

29.5.2007